A critical discovery in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer inhibitor protein is frequently disabled in many types of tumors, resulting https://7bookmarks.com/story21802627/vhh-fragments-revive-the-p53-protein-a-potential-pathway-for-malignant-treatment